Last news
Breakthroughs in Energy and Power, Advancements in Intelligent Technology -- The 2025 Chery International Technology Night

Breakthroughs in Energy and Power, Advancements in Intelligent Technology -- The 2025 Chery International Technology Night

WUHU, China, Oct. 19, 2025 /PRNewswire/ -- As the global new energy vehicle (NEV) industry accelerates toward electrification, hybrid technology has emerged as a crucial pathway, offering practical value and bridging the transition to full...

SingPost Launches Residential Posting Box Trial to Bring Postal Services Closer to Home

SingPost Launches Residential Posting Box Trial to Bring Postal Services Closer to Home

Drives Partnerships to Enhance Network for Greater Agility and Customer Convenience SingPost's service touchpoints expands to 2500 SINGAPORE, Oct. 19, 2025 /PRNewswire/ -- Singapore Post Limited (SingPost) is strategically positioning its national...

The 2025 Chery International User Summit Opens a New Chapter as AiMOGA Robotics Unveils Its Global Brand Strategy

The 2025 Chery International User Summit Opens a New Chapter as AiMOGA Robotics Unveils Its Global Brand Strategy

In today's rapidly evolving global industrial landscape, technological innovation has taken on a new mission. Its value now extends beyond individual product breakthroughs — toward building systemic ecosystems that integrate technology with users,...

Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting

Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting

AMT-253 is a potential first-in-class MUC18-directed ADC with a proprietary linker-payload design AMT-253 demonstrated a manageable safety profile, consistent with other TOP1-inhibitor based ADCs Promising antitumor activity was observed in heavily...

Wialon Announces Top 10 GPS Hardware Manufacturers for 2025

Wialon Announces Top 10 GPS Hardware Manufacturers for 2025

DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been recognized as the global leader in hardware for fleet management and digitalization, taking the #1 position in the Wialon GPS Hardware Manufacturers Top 10: 2025...

Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and...

From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use

From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use

Look Up Hong Kong-Ipsos survey of 651 parents backs a four-part plan for kids' wellbeing: delayed access to smartphones and social media, phone-free schools and more real-world activity and experiences. HONG KONG, Oct. 19, 2025 /PRNewswire/ -- Look...

From Presentation to Full-Service Reception: AiMOGA Robot Demonstrates "Human Assistant" Capabilities at the 2025 Chery Global Innovation Conference

From Presentation to Full-Service Reception: AiMOGA Robot Demonstrates "Human Assistant" Capabilities at the 2025 Chery Global Innovation Conference

WUHU, China, Oct. 19, 2025 /PRNewswire/ -- At the 2025 Chery Global Innovation Conference, an extraordinary "guest" took the stage — Mornine, the intelligent robot from AiMOGA Robotics. Opening in seven languages, she completed a fully autonomous...

menu
menu